PPT-Natalizumab ( Approved, Investigational)

DB ID DB09026 Category Immunosuppressive agents Half life 11 4 days Volume of distribution 57 19 L Multiple Sclerosis MS Patients 52 28 L Crohns

tysabri cells patients natalizumab cells tysabri natalizumab patients sclerosis multiple 300 usp dose infusion pml intravenous murine integrin hour

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/934668" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Natalizumab ( Approved, Investigational)" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.